On February 14, 2025, Ono Pharmaceuticals secured FDA approval for vimseltinib, a therapy for tenosynovial giant cell tumor (TGCT), which will be marketed as ROMVIMZA. This approval places Ono in direct competition with another Japanese pharmaceutical company, Daiichi Sankyo, in the TGCT…
Month: March 2025
NEW YORK, March 4, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of AppLovin Corporation (NASDAQ: APP) resulting from allegations that AppLovin may have issued materially…
WASHINGTON, March 4, 2025 /PRNewswire/ — NASA has selected Firefly Aerospace Inc. of Cedar Park, Texas, to provide the launch service for the agency’s Investigation of Convective Updrafts (INCUS) mission, which aims to understand why, when, and where tropical convective storms form, and…
BARCELONA, Španělsko, 4. března 2025 /PRNewswire/ — Yang Chaobin, ředitel představenstva a generální ředitel skupiny ICT Business Group společnosti Huawei, představil na prezentaci produktů a řešení Huawei (Huawei Product & Solution Launch) v rámci veletrhu MWC Barcelona 2025 síťové…
ROLLING MEADOWS, Ill., March 4, 2025 /PRNewswire/ — Arthur J. Gallagher & Co. today announced it has signed a definitive agreement to acquire San Francisco, California-based Woodruff Sawyer. The transaction is subject to regulatory approval and is expected to close during the second…
ATLANTA, March 4, 2025 /PRNewswire/ — Better Earth, a leading provider of compostable foodservice packaging solutions, is announcing the launch of its new Touch-Free Pressed Fiber Cutlery Dispenser. This dispenser offers a hygienic and sustainable alternative to traditional cutlery…
The All-New Multivitamin Delivers Whole-Body Benefits in a New Liquid Form That is Ready-to-Absorb Faster BRATTLEBORO, Vt., March 4, 2025 /PRNewswire/ — New Chapter®, a Vermont-based vitamin and supplement company with a mission to deliver the wisdom of Nature to nourish mind, body, and…
TULSA, Okla., March 4, 2025 /PRNewswire/ — AAON, Inc. (NASDAQ: AAON) (“AAON” or the “Company”), today announced that its Board of Directors has approved $30.0 million of share repurchases pursuant to the previously disclosed $100 million share repurchase program. Repurchases will be made…
On February 14, 2025, Ono Pharmaceuticals secured FDA approval for vimseltinib, a therapy for tenosynovial giant cell tumor (TGCT), which will be marketed as ROMVIMZA. This approval places Ono in direct competition with another Japanese pharmaceutical company, Daiichi Sankyo, in the TGCT…
BALTIMORE, March 4, 2025 /PRNewswire/ — The State of Maryland and Maryland Department of Juvenile Services (DJS) are being named in a civil complaint filed today alleging negligence that enabled the sexual assault of at least 69 children who were allegedly abused while housed at Charles…